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Abstract
In this issue of Chemistry & Biology, Arrendale and coworkers demonstrate a new prodrug 
strategy for intracellular delivery of an α, α-(difluoromethylene)phosphonate phosphoserine 
mimic. The deprotected pseudo-phosphopeptide releases the pro-apoptotic FOXO3a-transcription 
factor from its 14-3-3-adaptor protein complex, resulting in leukemic cell death.
Signal transduction in nature often involves protein phosphorylation. The combination of 
kinetic stability and thermodynamic lability of the phosphate ester renders it an excellent 
switch. Much of the kinetic stability to nucleophilic attack presumably derives from the 
negatively charged phosphoryl oxygens in its predominantly dianionic form (pKa2 ~6.5). 
Because of the ubiquity of phosphorylation as a signaling mechanism, chemical biologists 
have long sought to synthesize compounds that structurally and functionally mimic 
phosphate ester functionality but are resistant to phosphatase cleavage. Replacing the 
bridging oxygen with carbon confers such resistance, but simple CH2-bridged phosphonates 
have an elevated second pKa (7–7.5), exhibiting considerable monoanionic character. 
However, upon α-fluorination, the second pKa successively decreases in going from a CHF- 
(pKa ~6–6.5) to a CF2-bridge (pKa ~5–5.5). At the same time, C-C(H)(F)-P bond angle 
increases [e.g., from 112° (CH2) to 113° (CHF) to 117° (CF2) in a series studied by 
Nieschalk et al. (1996)], reaching an angle very close to the native C-O-P angle (119°) for 
the difluorinated phosphonate.
Such considerations led (Caplan et al. (2000) and others to regard α, α-
(difluoromethylene)phosphonates as “isopolar” and “isosteric” phosphate analogs. While the 
CF2-bridge clearly projects a larger van der Waals radius than the native bridging O, the fact 
that it expands the C-CF2-P bond angle lends some merit to the label “isosteric.” The 
“isopolar” nature of this functionality, on the other hand, is supported by DFT calculations 
on simple model compounds (Figure 1). The partial charge on the bridging phosphate ester 
oxygen (−0.453) is mimicked by the bridging CF2-phosphonate carbon (−0.395), especially 
when one considers the additional charge density on the pendant fluorines (−0.172 each).
Accordingly, in the 1990s, our group developed CF2-phosphonate analogs of pSer and pThr 
(Berkowitz et al., 1996, 1999) as tools for the study of protein phosphorylation (abbreviated 
pCF2-Ser; Panigrahi et al., 2009). Recent years have seen the very creative application of 
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(PPIs) that depend upon Ser/Thr phosphorylation. Paramount among these are the 
interactions of 14-3-3 adaptor proteins, ubiquitous “chaperones” that bind to phosphorylated 
partner proteins to modulate signal transduction, the cell cycle, intracellular trafficking and 
transcription.
Obsil et al. (2001) solved a prototypical 14-3-3-adaptor/phosphorylated-partner protein 
complex structure. The structure reveals in beautiful molecular detail how the 
phosphothreonine residue of the AANAT is tightly bound at a groove in the 14-3-3 dimer 
interface that is rich in H-bond donating residues, Y128, R86, and R127, resulting in a 
“molecular Velcro”-like interaction. The two arginine residues also appear to 
electrostatically pair with the pThr dianion, making this an ideal site to target with the CF2-
phosphonate functionality.
With the appearance of the paper in this issue of Chemistry & Biology by Arrendale et al. 
(2012), now two complementary approaches exist that, taken together, attest to the abililty 
of pCF2-Ser-bearing ligands to modulate 14-3-3-mediated PPIs. In earlier work, Zheng et al. 
(2005) modified the native protein itself, AANAT, using expressed protein ligation (EPL) 
technique to graft the phosphatase-inert pCF2-Ser residue onto position 205 of the wild-type 
protein. This effectively leads to a “constitutively phosphorylated” AANAT, remaining 
closely associated with its 14-3-3-zeta binding partner, and thereby stabilizing the protein to 
proteasomal degradation. In fact, using microinjection into CHO cells, Zheng et al. (2005) 
saw the persistence of this tight pCF2-Ser/14-3-3 interaction under intracellular conditions.
Very recently, Tarrant et al. (2012) have shown that this same strategy can be exploited to 
stabilize the important signal-transducing casein kinase II (CK2) kinase involved in cell 
proliferation. In this case, the PPI being targeted involves the CK2 interaction with the 
regulatory protein, Pin1. The CK2-Pin1 association is promoted by phosphorylation of 
Thr-344. Again utilizing EPL to incorporate pCF2-Ser at this site, Tarrant et al. (2012) were 
able to show that the semisynthetic CK2 binds tightly to its Pin1 regulatory protein partner, 
and that this interaction both stabilizes the protein to proteasomal degradation and alters its 
polypeptide substrate specificity.
Herein, Arrendale et al. (2012) first reports a new, efficient stereocontrolled synthesis of the 
pCF2-Ser building block, utilizing a nice stereo-retentive aziridine-opening. Arrendale et al. 
(2012) then truly open up a new vista in the application of this chemical biological tool by 
installing one of their trademark prodrug functionalities onto the fluorinated phosphonate 
and using this to deliver a carefully crafted pCF2-Ser-containing dipeptide ligand for the 
14-3-3 adaptor protein into the cell.
The elegant presumptive phosphonate release mechanism is depicted in Figure 2. The 5′-
nitrofuryl-2′-methyl N(4″-chlorobutyl)phosphonamido ester prodrugging strategy masks the 
fluorinated phosphonate as a neutral non-polar derivative, and subsequently promotes its 
release under reducing conditions within the cell. Reductive cleavage of the phosphonate 
ester, and subsequent ionization places more electron density on the amide nitrogen, 
permitting a Baldwin's rules-favored 5-exo-tet cyclization to a pyrrolidinium ring, also an 
excellent leaving group. Hydrolysis and ionization then give the free phosphonate dianion.
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In the case at hand, the released modified dipeptide ligand successfully competes, in vivo, 
with the phosphorylated FOXO3a transcription factor for its 14-3-3 adaptor protein, thereby 
effectively titrating off the adaptor at micromolar ligand concentrations. Applied to 
leukemia cells, the authors show that this 14-3-3-sequestering strategy can be used to induce 
the pro-apoptotic effects of the free FOXO3a protein, with attendant anti-leukemic activity.
These studies expand the domain in which such “teflon phosphates” may be deployed to ask 
fundamental questions in chemical biology, allowing for their transport into the cell. Given 
recent exciting developments in photocaging/release of native pSer functionality from the 
Imperiali lab (Goguen et al., 2011), it will be interesting to see if this strategy can be 
expanded to include wavelength specific photolabile prodrug functionalities for pCF2Ser. 
One can imagine thusly asking more finely tuned questions relating to the temporal 
regulation of protein function via phosphorylation. Clearly, given the abundance of 14-3-3 
adaptor protein-mediated regulatory interactions, both this work and the complementary 
protein-grafting work in the Cole group open up important horizons for the interrogation of 
phosphorylation-dependent PPIs with this chemical biological tool.
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Figure 1. Fluorinated Phosphonates versus Phosphates: A Computational Comparison
Electrostatic potential (ESP) maps were generated from DFT calculations with Gaussian 
03W using the B3LYP function at the 6-311+g(d,p) level. Calculations were performed on 
full ground state optimizations, plus frequencies. ESP maps were generated in Gaussview 
3.0. Isosurfaces were generated with a total charge density of 0.0004 e/bohr. Note that the 
charge distribution shown is for the minimum energy conformer located. At room 
temperature, rapid single bond rotation should lead to equal charge distribution across the 
three anionic phosph(on)ate oxygens.
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Figure 2. Prodrug Release Mechanism
Depicted is the putative mechanism of intracellular prodrug activation, under reductive 
conditions, for the pCF2-Ser-containing dipeptide ligand for the 14-3-3 adapter protein.
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